ADRIACELL
Adriacell is a biotech company whose focus is the development of solutions (treatment and diagnostics) for tumors characterized by low probability of survival for patients and of anti infective agents. It leverages its efforts and scientific expertise to (i) develop a new class of anti-tumor therapeutics and (ii) create a series of powerful diagnostics for the early detection of cancer progression. The company is also developing new and highly powerful delivery solutions through small molecules... as the basis for a new class of anti-infective drugs. Adriacell owns a patented system that can be used for the study of events subsequent to DNA double strand breaks, which is a very important issue for cancer research and diagnostics. The company is currently evaluating a new class of therapeutics for cancer; its main compound is about to enter the pharmacokinetic and toxicology phases.
ADRIACELL
Industry:
Biotechnology Health Diagnostics
Founded:
2004-01-01
Address:
Basovizza, Friuli-Venezia Giulia, Italy
Country:
Italy
Website Url:
http://www.adriacell.com
Status:
Closed
Contact:
215-538-1983
Email Addresses:
[email protected]
Similar Organizations
Escend Pharmaceuticals
Escend Pharmaceuticals offers cancer therapeutics services.
ImCure Therapeutics
ImCure Therapeutics
Meristem Therapeutics
Meristem Therapeutics
Pathfinder Therapeutics
Pathfinder Therapeutics
Senexta Therapeutics
Senexta Therapeutics
Solaris Therapeutics
Solaris Therapeutics
More informations about "Adriacell"
Adriacell - Crunchbase Company Profile & Funding
Adriacell owns a patented system that can be used for the study of events subsequent to DNA double strand breaks, which is a very important issue for cancer research and diagnostics. …See details»
Adriacell - Products, Competitors, Financials, Employees, …
About Adriacell. Adriacell s.r.l is a biotech company focused in oncology pharmaceuticals founded in Basovizza (Trieste) in March 2004 by Prof. Christian Kuehne, an Austrian citizen.nThe …See details»
Adriacell S.p.A. - Life-Sciences-Europe.com
Jun 1, 2011 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Adriacell SpA - Drug pipelines, Patents, Clinical trials - Synapse
Explore Adriacell SpA with its drug pipeline, therapeutic area, technology platform, , Drug:CROMOC-36.See details»
Adriacell SpA:Company Profile & Technical Research,Competitor …
Adriacell SpA is a company that provides Infective Agent, Double strand, Anti-Infective Agents and more. Adriacell SpA is headquartered in Italy . Adriacell SpA was founded in 2004. …See details»
Adriacell S P A Trademarks & Logos - US Patent and Trademark …
Adriacell S P A USPTO Trademark & Patent Filings. Trademark applications and grants for Adriacell S P A. Adriacell S P A has 1 trademark applications. The latest application filed is for …See details»
Adriacell Pharmaceuticals - Company Profile and News
Company profile page for Adriacell Pharmaceuticals including stock price, company news, executives, board members, and contact informationSee details»
CERVIMAX Trademark of Adriacell S.p.A.. Application Number: …
CERVIMAX is a trademark and brand of Adriacell S.p.A., Trieste-Basovizza 34012, ITALY. This trademark was filed to EUIPO on Thursday, June 10, 2010. The CERVIMAX is under the …See details»
Adriacell Management Team - CB Insights
Explore {Adriacell's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
AdriaCell SpA - biobank
AdriaCell SpA . AREA Science Park. Trieste. TS 34100 Italy +39-040-375-7770 +39-040-375-7773: www.adriacell.com : Therapeutic Development Program Steering Committee is …See details»
Adriacell - VentureRadar
Adriacell SRL is developing a new generation of biopharmaceuticals for the therapy of cancer patients, the CROMOC compound class., which are fusion proteins of potent active principles …See details»
Adriacell (Group) - life-sciences-europe.com
Upcoming Events. EUROMAR 2024 Bilbao; J.P. Morgan 43rd Annual Healthcare Conference 2025 San Francisco; BayOConnect 2024 München (Munich) – Forum for Biotech & LifeScienceSee details»
Adriacell - Company Profile - Tracxn
Nov 27, 2024 Adriacell - Developing an Immuno-diagnostic for early detection and peptide conjugated drugs for treatment of cancer. This company is not active anymore. Founded by …See details»
Adriacell - Crunchbase
Anti-tumor therapeuticsSee details»
Adriacell Company Insights, Tech Stack, and Competitors | 6sense
Find useful insights on Adriacell’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Adriacell.See details»
Adriacell Staff Directory & Email Format - ContactOut
Explore Adriacell staff directory for direct access to contact details on 3 employees including email format, email address and phone numbers.See details»
Adriacell Stock Price, Funding, Valuation, Revenue ... - CB Insights
See Adriacell funding rounds, investors, investments, exits and more. Evaluate their financials based on Adriacell's post-money valuation and revenue. Adriacell Stock Price, Funding, …See details»
Research programme: DNA synthesis inhibitors - Adriacell
Adriacell Pharmaceuticals is developing biomolecules which inhibit DNA synthesis through double-strand breakage, for the treatment of cancer and inflammation. Research programme: …See details»
Top Adriacell Alternatives, Competitors - CB Insights
See how Adriacell compares to similar products. Adriacell's top competitors include Trellis Bioscience, Aerie, and Sierra Oncology. Trellis Bioscience. Unclaimed. Trellis Bioscience …See details»
Adria Mobil Corpo Page
Adria Mobil aims to achieve and maintain the highest internationally recognised level of quality performance. To this end, we are continuously improving and implementing the principles of …See details»